New Key Statistics Module, Z-Score and F-Score
NAS:AUPH Key Ratios
| Market Cap $ M | 759.43 |
| Enterprise Value $ M | 512.33 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 133.67 |
| Price/Book | 2.12 |
| Price/Sales | 3.98 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 191.00 |
| EPS (TTM) $ | -0.42 |
| Beneish M-Score | -3 |
| 10-y EBITDA Growth Rate % | -0.40 |
| 5-y EBITDA Growth Rate % | 6.30 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -8.89 |
| EV-to-EBITDA | -12.23 |
| PEG | -- |
| Shares Outstanding M | 143.02 |
| Net Margin (%) | -32.69 |
| Operating Margin % | -35.88 |
| Pre-tax Margin (%) | -32.24 |
| Quick Ratio | 5.05 |
| Current Ratio | 5.60 |
| ROA % (ttm) | -11.94 |
| ROE % (ttm) | -16.36 |
| ROIC % (ttm) | -52.09 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.02 |
AUPH Number of Guru Trades
AUPH Volume of Guru Trades
Gurus Latest Trades with NAS:AUPH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AUPH is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Aurinia Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:AUPH
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers